Inhibition of IL-1β and IL-6 in osteoblast-like cell by isoflavones extracted fromSophorae fructus

Archives of Pharmacal Research

Volumn 26, Issue 12, 2003, Pages 1029-1035

  Joo, Seong Soo ^a   Kang, Hee Cheol ^a   Lee, Min Won ^a   Choi, Young Wook ^a   Lee, Do Ik ^a  

^a Chung Ang University   (South Korea)

Author keywords

Isoflavone; Local factors; Nitric oxide; Osteoclastogenesis; Sophorae fructus

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; ISOFLAVONE DERIVATIVE; PLANT EXTRACT;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; OSTEOBLAST; PHYSIOLOGY; RAT; SOPHORA; SPRAGUE DAWLEY RAT;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; ISOFLAVONES; OSTEOBLASTS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SOPHORA;

EID: 4143069009     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/BF02994754     Document Type: Article

References (27)

1. Adlercreutz, H., Phyto-oestrogens and cancer.Lancet Oncology, 3, 364–373 (2002). DOI: 10.1016/S1470-2045(02)00777-5
2. Amonkar, M. M. and Mody, R., Developing profiles of postmenopausal women being prescribed oestrogen therapy to prevent osteoporosis.J. Commun. Health, 27, 335–350 (2002). DOI: 10.1023/A:1019836610275
3. Armour, K. E. and Ralston, S. H., Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells.Endocrinology, 139, 799–802 (1998). DOI: 10.1210/en.139.2.799
4. Duncan, A. M., Phipps, W. R., and Kurzer, M. S., Phytooestrogen.Best Practice & Research Clinical Endocrinology and Metabolism, 17, 253–271 (2003). DOI: 10.1016/S1521-690X(02)00103-3
5. Eastel, R., Treatment of postmenopausal osteoporosis.N. Engl. J. Med., 338, 736–746 (1998). DOI: 10.1056/NEJM199803123381107
6. Felix, R., Cecchini, M. G., Hofstetter, W., Elford, P. R., Stutzer, A., and Fleishi, H., Impatient of macrophage colonystimulating factor production and lack of resident bone marrow macrophage in the osteoporotic op/op mouse.J. Bone Miner. Res., 5, 781–789 (1990). DOI: 10.1002/jbmr.5650050716
7. Fujikawa, Y., Sabokbar, A., Neale, D., Itonaga, I., Torisu, T., and Athanasou, A., The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-α, and granulocyte macrophagecolony stimulating factor) on human osteoclast formation from circulating cells.Bone, 28, 261–267 (2001). DOI: 10.1016/S8756-3282(00)00453-1
8. Greenfield, E. M., Bi, Y., and Miyauchi, A., Regulation of osteoclast activity.Life Sicence, 65, 1087–1102 (1999). DOI: 10.1016/S0024-3205(99)00156-3
9. Joo, S. S., Chang, J. K., Park, J. H., Kang, H. C., and Lee, D. I., Immuno activation of lectin-conjugated praecoxin A on IL-6, IL-12 expression.Arch. Pharm. Res., 25, 954–963 (2002). DOI: 10.1007/BF02977019
10. Klein-Nulend, J., Helfrich, M. H., Sterck, J. G., MacPherson, H., Joldersma, M., Ralson, S. H., Semeins, C. M., and Burger, E. H., Nitric oxide response to shear stress by human bone cell culture is endothelial nitric oxide synthase dependant.Biochem. Biophys. Res. Commun., 250, 108–114 (1998). DOI: 10.1006/bbrc.1998.9270
11. 2, interleukin 1α, and tumor necrosis factor-a increase human osteoclast formation and bone resorptionin vitro.Endocrinology, 139, 3157–3164 (1998). DOI: 10.1210/en.139.7.3157
12. Maclntyre, I., Zaidi, M., Towhidul Alam, A. S. M., Datta, H. K., Moonga, B. S., Lidbury, P. S., Hecker, M., and Vane, J. R., Osteoclastic inhibition: An action of nitric oxide not mediated by cyclic GMP.Proc. Natl. Acad. Sci. USA, 88, 2936–2940 (1991). DOI: 10.1073/pnas.88.7.2936
13. Messina, M. and Messina, V., Soyfood, soybean isoflavone, and bone health: a brief overview.J. Ren. Nutri., 10, 63–68 (2000). DOI: 10.1016/S1051-2276(00)90001-3
14. Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Yano, K., Morinaga, T., and Higashio, K., RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.Biochem. Biophys. Res. Commun., 253, 395–400 (1998). DOI: 10.1006/bbrc.1998.9788
15. Pacifici, R., Cytokines, estrogen and postmenopausal osteoporosis-the second decade.Endocrinology, 139, 2659–2661 (1998). DOI: 10.1210/en.139.6.2659
16. Ragab, A. A., Nalepka, J. L., Bi, Y., and Greenfield, E. M., Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells.Am. J. Physiol. Cell Physiol., 283, C679-C687 (2002).
17. Raisz, L. G., The osteoporosis revolution.Ann. Intern. Med., 126, 458–462 (1997).
18. Riggs, B. L., Khosia, S., and Melton, L. J., A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.J. Bone Miner. Res., 13, 763–773 (1998). DOI: 10.1359/jbmr.1998.13.5.763
19. Setchell, K. D., Abstract presented at: Second international symposium on the role of soy in preventing and treating chronic disease. Brussel Belgium, (1996).
20. Stanley, E. R. and Heard, R M., Factors regulating macrophage production and growth: Purification and some properties of the colony-stimulating factor from medium conditioned by mouse L cells.J. Biol. Chem., 252, 4305–4321 (1977).
21. Swolin-Eide, D. and Ohlsson, C., Effects of Cortisol on the expression of interleukin-6 and interleukin-1 in human osteoblast like cells.J. Endocrinology, 156, 107–114 (1998). DOI: 10.1677/joe.0.1560107
22. Tai, H., Miyaura, C., Pilbeam, C. C., Tamura, T., Ohsugi, Y., Koishihara, Y., Kubodera, N., Kawaguchi, H., Raisz, L. G., and Suda, T., Transcriptional induction of cyclooxygenase-2 in osteoblast is involved in interleukin-6-induced osteocalst formation.Endocrinology, 138, 2372–2397 (1997). DOI: 10.1210/en.138.6.2372
23. Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Akatsu, T., Koishihara, Y., Ohsugi, Y., Kumaki, K., Taga, T., Kishmoto, T., and Suda, T., Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6.Proc. Natl. Acad. Sci. USA, 90, 11924–11928 (1993). DOI: 10.1073/pnas.90.24.11924
24. Udagawa, N., Takahashi, N., Matsuzaki, K., Jimi, E., Tsurukai, T., Itoh, K., Nakagawa, H., Yasuda, H., Goto, M., Tsuda, E., Higashio, K., Martin, T J., and Suda, T., Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.Bone, 5, 517–523 (1999). DOI: 10.1016/S8756-3282(99)00210-0
25. vant Hof, R. J. and Ralston, S. H., Nitric oxide and bone.Immunology, 103, 255–261 (2001). DOI: 10.1046/j.1365-2567.2001.01261.x
26. Wimalawansa, S. J., De Marco, G., Gangula, P., and Yallampalli, Nitric oxide donor alleviates ovariectomy-induced bone loss.Bone, 18, 301–304 (1996). DOI: 10.1016/8756-3282(96)00005-1
27. Yamaguchi, M. and Gao, Y H., Inhibitory effect of genistein on bone resorption in tissue culture.Biochem. Phamacol., 55, 71–76 (1998). DOI: 10.1016/S0006-2952(97)00402-4